Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience today reported an 11 percent year-over-year decrease in its fiscal second quarter revenues, which it attributed to a 16 percent drop in diagnostics segment sales.

Separately, the company announced today that it will acquire molecular diagnostics maker GenePOC for up to $120 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.